What the Research Says
Alpha-GPC has moderate clinical evidence supporting its use for cognitive enhancement and athletic performance. De Jesus Moreno (2003) conducted the largest trial, showing significant cognitive improvements in 261 Alzheimer's patients at 1200mg/day over 180 days. Ziegenfuss et al. (2008) established its ergogenic potential, demonstrating a 14% increase in peak force production. As a choline source, Alpha-GPC delivers approximately 40% choline by weight, making it the most efficient supplemental source for raising brain acetylcholine levels.
